Roche Grows in 2012 – Analyst Blog

By: Stock Market News & Stocks to Watch from StraightStocks

Posted on February 01, 2013 at 14:15 PM EST

Roche recently reported 2012 results. Revenues grew 4% year over year to CHF 45.5 billion driven by solid demand for its cancer drugs and increased sales of diagnostic tests to clinical laboratories.

Related Stocks:

Bayer Aktiengesellschaft American Depositary Shares Eli Lilly & Co. Novo Nordisk A/S ADS Roche Holding AG Basel American Depositary Shares

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates